Cervical Spinal Fusion (ACDF)
Comprehensive surgical technique guide for Anterior Cervical Discectomy and Fusion (ACDF) - evidence-based approach for cervical degenerative disease
Reviewed by OrthoVellum Editorial Team
Editorial maintenance, source checking, and correction workflow • Published by OrthoVellum Medical Education Team
ANTERIOR CERVICAL DISCECTOMY & FUSION (ACDF)
Gold standard surgical approach for cervical degenerative disease with neural compression - Smith-Robinson technique with contemporary instrumentation | intermediate
Five Critical Anatomical Danger Zones
Recurrent Laryngeal Nerve
Location: Travels in tracheoesophageal groove - RIGHT side more vulnerable (loops under subclavian at T1-2, ascends obliquely). LEFT side loops predictably under aortic arch.
Protection: Left-sided approach preferred. Avoid retractor placement in tracheoesophageal groove. Endotracheal tube pressure monitoring - deflate/reposition q30min. Intraoperative neuromonitoring if revision/multilevel surgery.
Superior Laryngeal Nerve
Location: Exits vagus at C3 level, travels deep to carotid to pierce thyrohyoid membrane. At risk with high approaches (C3-4, C2-3) or excessive superior retraction.
Protection: Dissect only to level of surgical exposure required. Gentle superior retraction with handheld Cloward retractors. Avoid monopolar diathermy near carotid sheath above C4.
Vertebral Artery
Location: Enters transverse foramen C6 (90%) or C5 (8%). Courses 3mm lateral to uncovertebral joint. Anomalous course in 5% (medial deviation).
Protection: Limit lateral dissection to medial border of uncinate process. Preoperative CTA if revision surgery or dysplastic anatomy. Angled curettes directed medially only. Uncovertebral drilling with 3mm diamond burr at 45° trajectory.
Spinal Cord
Location: Average AP diameter cervical canal 14mm (range 10-20mm). Cord occupies 12mm - CSF 1mm anterior. Stenotic canal means minimal safety margin with instruments.
Protection: Decompress lateral-to-medial sequence. Kerrison rongeurs bite away from cord (upbiting). Trial spacer before final implant - oversizing risks cord compression. Intraoperative SSEPs/MEPs for stenotic canals or ossification of PLL.
Esophagus
Location: Immediately medial to dissection plane. Thin wall (3mm) highly vulnerable to retractor pressure, diathermy thermal injury, or sharp dissection.
Protection: Handheld retraction initially until NG tube palpated. Smooth blade retractors (not teeth). Retract esophagus gently medially - limit pressure (60-80mmHg max). Irrigate frequently. Bipolar only near midline. Methylene blue swallow test if concern.
POETSACDF Approach Layers - 'POETS'
DUBSACDF Decompression Sequence - 'DUBS'
Primary Indications
Absolute Indications
- Progressive cervical myelopathy with cord compression (modified JOA score decline)
- Cervical radiculopathy failing 6-12 weeks conservative management with MRI-confirmed nerve root compression
- Cervical kyphotic deformity with anterior column deficiency requiring reconstruction
- Post-traumatic cervical instability (facet disruption, ALL/disc injury) requiring stabilization
- Anterior cervical tumor/infection requiring corpectomy and reconstruction
Relative Indications
- Cervical radiculopathy with concordant imaging and high-demand occupation
- Multilevel cervical spondylosis with predominant axial neck pain (controversial - consider arthroplasty)
- Soft disc herniation with persistent radicular symptoms despite optimized non-operative care
- Adjacent segment disease following prior cervical fusion
Contraindications
- Absolute: Active systemic infection, severe osteoporosis (DEXA T-score less than -3.5), medical instability
- Relative: Multilevel disease (greater than 3 levels - consider hybrid constructs), smoker (2.7x pseudarthrosis risk), significant dysphagia baseline, ankylosing spondylitis (avoid through fused segments)
Preoperative Planning Essentials
Imaging Analysis
- MRI: T2 signal changes in cord (myelomalacia poor prognosis), disc hydration, foraminal stenosis grade
- CT: Assess ossification of PLL (40% Asian population), uncovertebral hypertrophy, facet arthropathy
- Flexion-extension radiographs: Document instability (greater than 3mm translation or greater than 11° angulation)
- CTA: If revision surgery (scar tissue distorts anatomy) or vascular anomaly suspected
Patient Optimization
- Smoking cessation 8 weeks minimum (proven 3x fusion rate improvement)
- Diabetic HbA1c less than 7.5% (wound healing, infection risk reduction)
- BMI optimization - obesity associated with higher dysphagia, revision rates
- Discontinue NSAIDs 1 week preoperatively (theoretical fusion concern)
Graft and Instrumentation Selection
- Autograft iliac crest: Gold standard fusion (98% single-level) but donor site pain 20%
- Allograft structural: Equivalent fusion with anterior plating (95% vs 98%), no donor morbidity
- PEEK cage with demineralized bone matrix: Contemporary standard - subsidence risk 5-8%
- Anterior cervical plate: Reduces pseudarthrosis 3-level from 44% to 8%, angular kyphosis
- Zero-profile devices: Standalone cage with integrated screws - lower dysphagia (12% vs 28% at 3 months)
Postoperative Care Protocol
Immediate Postoperative (0-24 hours)
- Monitor airway closely in PACU - risk of hematoma, edema, RLN palsy (keep anesthesia available)
- Soft cervical collar for comfort (not structural - fusion relies on graft/plate, not collar)
- Head of bed elevated 30° (reduce venous pressure, swelling)
- Ice packs to anterior neck (reduce edema)
- Diet: Clear liquids advance to soft diet as tolerated (dysphagia common 70% at 1 week)
- Remove drain (if placed) when output less than 30mL per 8 hours (typically POD1)
Early Recovery (1-6 weeks)
- Mobilize immediately - no bed rest required
- Collar weaned over 2 weeks (comfort only, not necessary for fusion)
- Avoid heavy lifting (greater than 10 pounds), contact sports, extreme neck movements (extension/rotation)
- Radiographs at 2 weeks (AP, lateral) - assess alignment, hardware position
- Sutures removed 10-14 days (if non-absorbable used)
- Return to desk work 2-4 weeks, manual labor 6-12 weeks
Late Recovery (6 weeks to 1 year)
- Flexion-extension radiographs at 3 months (assess early fusion)
- CT scan at 6-12 months if concern for pseudarthrosis (persistent pain, no bridging bone on radiographs)
- Physical therapy if neck stiffness, periscapular pain (common 40%)
- Fusion confirmed radiographically: Bridging bone across graft, less than 2mm motion on flexion-extension, less than 5° angular change
VTE Prophylaxis
- Low risk surgery (1-2 hours, minimal blood loss) - early mobilization sufficient
- High-risk patients (obesity BMI greater than 35, prior VTE, cancer, prolonged surgery greater than 3 hours) - sequential compression devices, LMWH (enoxaparin 40mg daily) starting POD1 (avoid preoperative dosing - hematoma risk)
Pain Management
- Multimodal analgesia: Paracetamol 1g QID, gabapentin 300mg TID (radicular pain)
- Opioids as needed (oxycodone 5-10mg q4-6h) - minimize duration (risk dependency)
- Avoid NSAIDs first 3 months (theoretical concern for fusion - controversial, weak evidence)
- Ice therapy, gentle ROM exercises
Exam Viva Scenarios
Practice these scenarios to excel in your viva examination
"A 52-year-old lawyer presents with 8 months of right arm pain radiating to the thumb and index finger, with numbness. MRI shows a right C6-7 paracentral disc herniation compressing the C7 nerve root. He has failed 3 months of physiotherapy and anti-inflammatories. How would you manage this patient and what are the key operative steps if you proceed with ACDF?"
"During ACDF at C5-6, after anterior discectomy you are performing posterior decompression with a Kerrison rongeur when you encounter brisk arterial bleeding from the left lateral disc space. What has happened, what are your immediate steps, and how do you prevent this complication?"
"You are planning ACDF for a 45-year-old manual laborer with C5-6 and C6-7 disc herniations causing bilateral arm pain. What are your graft options and how would you counsel the patient regarding fusion rates, complications, and expected functional outcomes for two-level ACDF?"
ACDF - Exam Day Essentials
High-Yield Exam Summary
References
-
Smith GW, Robinson RA. The treatment of certain cervical-spine disorders by anterior removal of the intervertebral disc and interbody fusion. J Bone Joint Surg Am. 1958;40-A(3):607-624. Original description of anterior cervical approach and interbody fusion technique - established ACDF as gold standard treatment for cervical disc disease.
-
Bohlman HH, Emery SE, Goodfellow DB, Jones PK. Robinson anterior cervical discectomy and arthrodesis for cervical radiculopathy. Long-term follow-up of one hundred and twenty-two patients. J Bone Joint Surg Am. 1993;75(9):1298-1307. Demonstrated 92% fusion rate with autograft and anterior plating versus 67% without plating for multilevel ACDF - established role of anterior instrumentation.
-
Hilibrand AS, Carlson GD, Palumbo MA, Jones PK, Bohlman HH. Radiculopathy and myelopathy at segments adjacent to the site of a previous anterior cervical arthrodesis. J Bone Joint Surg Am. 1999;81(4):519-528. Defined adjacent segment disease - 2.9% annual incidence, 25% cumulative at 10 years post-ACDF, established importance of maintaining cervical lordosis.
-
Wang JC, McDonough PW, Endow KK, Delamarter RB. Increased fusion rates with cervical plating for two-level anterior cervical discectomy and fusion. Spine. 2000;25(1):41-45. Meta-analysis showing fusion rates: autograft 93%, allograft 88%, anterior plating improves both to 96-98% - evidence base for routine plating in multilevel surgery.
-
Riley LH 3rd, Skolasky RL, Albert TJ, Vaccaro AR, Heller JG. Dysphagia after anterior cervical decompression and fusion: prevalence and risk factors from a longitudinal cohort study. Spine. 2005;30(22):2564-2569. Demonstrated dysphagia incidence 50-60% at 1 month, 12-14% at 12 months, identified multilevel surgery and prominent hardware as risk factors - established importance of low-profile implants.
-
Fountas KN, Kapsalaki EZ, Nikolakakos LG, et al. Anterior cervical discectomy and fusion associated complications. Spine. 2007;32(21):2310-2317. Comprehensive complication analysis: RLN palsy 1-8%, vertebral artery injury 0.3-0.5%, postoperative hematoma 0.5-2%, esophageal injury 0.1-0.25% - established complication benchmarks for quality improvement.
-
Yue WM, Brodner W, Highland TR. Long-term results after anterior cervical discectomy and fusion with allograft and plating: a 5- to 11-year radiologic and clinical follow-up study. Spine. 2005;30(19):2138-2144. Demonstrated equivalent fusion rates allograft with plating (95%) versus autograft (98%) with no donor site morbidity - shifted practice toward allograft as contemporary standard.
-
Basques BA, Anandasivam NS, Webb ML, et al. Risk factors for blood transfusion with primary posterior lumbar fusion. Spine. 2015;40(18):1792-1797. Identified obesity, multilevel surgery, operative time greater than 3 hours as transfusion risk factors - informs preoperative optimization and blood conservation strategies.
-
Shin DA, Yi S, Yoon DH, Kim KN, Shin HC. Artificial disc replacement combined with fusion versus two-level fusion in cervical two-level disc disease. Spine. 2014;39(15):1233-1239. Hybrid constructs (arthroplasty + fusion) for two-level disease showed superior ROM preservation and similar clinical outcomes versus two-level ACDF - emerging alternative to consider.
-
Australian Orthopaedic Association National Joint Replacement Registry. Hip, Knee & Shoulder Arthroplasty: 2023 Annual Report. Adelaide: AOA; 2023. Australian registry data showing 15,000 ACDF procedures annually, infection rate 0.8%, reoperation 3.2% at 2 years - benchmark outcomes for Australian practice.